-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

Benzinga·09/10/2026 13:13:40
Listen to the news
Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.